GEMMA and MALDI-TOF MS of reactive PEGs for pharmaceutical applications

Journal of Pharmaceutical and Biomedical Analysis

Volumn 52, Issue 4, 2010, Pages 432-437

  Kemptner, Jasmin ^a   Marchetti Deschmann, Martina ^a   Siekmann, Juergen ^b   Turecek, Peter L ^b   Schwarz, Hans Peter ^b   Allmaier, Günter ^a  

^a VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^b Baxter Innovations   (Austria)

Author keywords

GEMMA; MALDI; Mass spectrometry; Molecular weight determination; Poly(ethylene) glycol; Size determination

Indexed keywords

FUNCTIONAL GROUP; MACROGOL DERIVATIVE; METHOXYLATED POLYETHYLENE GLYCOL SUCCINIMIDYL SUCCINATE; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ARTICLE; CHEMICAL STRUCTURE; CRYSTALLIZATION; ELECTROPHORETIC MOBILITY; INTERMETHOD COMPARISON; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR SIZE; MOLECULAR WEIGHT; POLYDISPERSITY VALUE; PRIORITY JOURNAL; CHEMISTRY; COMPARATIVE STUDY; ELECTROSPRAY MASS SPECTROMETRY; MASS SPECTROMETRY; PHARMACEUTICS; PROCEDURES;

MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TECHNOLOGY, PHARMACEUTICAL;

EID: 77950371194     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.01.017     Document Type: Article

References (47)

1. Vicent M.J., Duncan R. Polymer conjugates: nanosized medicines for treating cancer. Trends Biotechnol. 2006, 24:39-47.
2. Khandare J., Minko T. Polymer-drug conjugates: progress in polymeric prodrugs. Progr. Polym. Sci. 2006, 31:359-397.
3. Werle M., Bernkop-Schnuerch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids 2006, 30:351-367.
4. Shechter Y., Mironchik M., Saul A., Gershonov E., Precido-Patt L., Sasson K., Tsubery H., Mester B., Kapitkovsky A., Rubinraut S., Vachutinski Y., Fridkin G., Fridkin M. New technologies to prolong life-time of peptide and protein drugs in vivo. Intern. J. Pept. Res. Ther. 2006, 13:105-117.
5. Abuchowski A., van Es T., Palczuk N.C., Davis F.F. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 1977, 252:3578-3581.
6. Veronese F.M., Caliceti P., Schiavon O. Branched and linear poly(ethylene glycol): influence of the polymer structure on enzymological, pharmacokinetic, and immunological properties of protein conjugates. J. Bioact. Compat. Polym. 1997, 12:196-207.
7. Veronese F.M., Pasut G. PEGylation, successful approach to drug delivery. Drug Discovery Today 2005, 10:1451-1458.
8. Pasut G., Sergi M., Veronese F.M. Anti-cancer PEG-enzymes: 30 years old, but still a current approach. Adv. Drug Deliv. Rev. 2008, 60:69-78.
9. Torchilin V.P., Voronkov Y.I., Mazaev A.V. The use of immobilized streptokinase. (Streptodekaza) for the therapy of thromboses. Therap. Arch. (Russia) 1982, 54:21-25.
10. Mehvar R. Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: pharmacokinetic and pharmacodynamic perspectives. Curr. Pharm. Biotechnol. 2003, 4:283-302.
11. Langer C.J. CT-2103: a novel macromolecular taxane with potential advantages compared with conventional taxanes. Clin. Lung Cancer 2004, 6(Suppl 2):S85-88.
12. Pasut G., Veronese F.M. Polymer-drug conjugation, recent achievements and general strategies. Prog. Polym. Sci. 2007, 32:933-961.
13. Roberts M.J., Bentley M.D., Harris J.M. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 2002, 54:459-476.
14. Working P.K., Newman S.S., Johnson J., Cornacoff J.B. Saftey of poly(ethylene glycol) derivatives, in Poly(ethylene glycol) chemistry and biological applications. Poly(ethylene glycol) Chemistry and Biological Applications 1997, 45-54. ACS, Washington, DC, USA. J.M. Harris, S. Zalipsky (Eds.).
15. Bailon P., Berthold W. Polyethylene glycol-conjugated pharmaceuticals proteins. Pharm. Sci. Technol. Today 1998, 1:352-356.
16. Caliceti P., Veronese F.M. Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates. Adv. Drug Deliv. Rev. 2003, 55:1261-1277.
17. Katre N.V. Immunogenicity of recombinant IL-2 modified by covalent attachment of polyethylene glycol. J. Immunol. 1990, 144:209-213.
18. Kamisaki Y., Wada H., Yagura T., Matsushima A., Inada Y. Reduction in immunogenicity and clearance rate of Escherichia coli l-asparaginase by modification with monomethoxypolyethylene glycol. J. Pharmacol. Exp. Ther. 1981, 216:410-414.
19. Nucci M.L., Olejarczyk J., Abuchowski A. Immunogenicity of polyethylene glycol-modified superoxide dismutase and catalase. J. Free Radical Biol. Med. 1986, 2:321-325.
20. Davis S., Abuchowski A., Park Y.K., Davis F.F. Alteration of the circulating life and antigenic properties of bovine adenosine deaminase in mice by attachment of polyethylene glycol. Clin. Exp. Immunol. 1981, 46:649-652.
21. Tsuji J., Hirose K., Kasahara E., Naitoh M., Yamamoto I. Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase. Int. J. Immunopharmacol. 1985, 7:725-730.
22. He X.H., Shaw P.C., Xu L.H., Tam S.C. Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity. Life Sci. 1999, 64:1163-1175.
23. Knauf M.J., Bell D.P., Hirtzer P., Luo Z.P., Young J.D., Katre N.V. Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water-soluble polymers. J. Biol. Chem. 1988, 263:15064-15070.
24. Satake-Ishikawa R., Ishikawa M., Okada Y., Kakitani M., Kawagishi M., Matsuki S., Asano K. Chemical modification of recombinant human granulocyte colony-stimulating factor by polyethylene glycol increases its biological activity in vivo. Cell Struct. Funct. 1992, 17:157-160.
25. Abuchowski A., McCoy J.R., Palczuk N.C., van Es T., Davis F.F. Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 1977, 252:3582-3586.
26. Bailon P., Palleroni A., Schaffer C.A., Spence C.L., Fung W.J., Porter J.E., Ehrlich G.K., Pan W., Xu Z.X., Modi M.W., Farid A., Berthold W., Graves M. Rational design of a potent, long-lasting form of interferon: a 40kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. Bioconj. Chem. 2001, 12:195-202.
27. Levy Y., Hershfield M.S., Fernandez-Mejia C., Polmar S.H., Scudiery D., Berger M., Sorensen R.U. Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase. J. Pediatr. 1988, 113:312-317.
28. Wong S.S. Chemistry of Protein Conjugation and Cross-Linking 1991, CRC Press, Boca Raton, FL, USA.
29. Trainer P.J., Drake W.M., Katznelson L., Freda P.U., Herman-Bonert V., van der Lely A.J., Dimaraki E.V., Stewart P.M., Friend K.E., Vance M.L., Besser G.M., Scarlett J.A., Thorner M.O., Parkinson C., Klibanski A., Powell J.S., Barkan A.L., Sheppard M.C., Malsonado M., Rose D.R., Clemmons D.R., Johannsson G., Bengtsson B.A., Stavrou S., Kleinberg D.L., Cook D.M., Phillips L.S., Bidlingmaier M., Strasburger C.J., Hackett S., Zib K., Bennett W.F., Davis R.J. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N. Engl. J. Med. 2000, 342:1171-1177.
30. Wang Y.S., Youngster S., Grace M., Bausch J., Bordens R., Wyss D.F. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv. Drug Deliv. Rev. 2002, 54:547-570.
31. Graham M.L. Pegaspargase: a review of clinical studies. Adv. Drug Deliv. Rev. 2003, 55:1293-1302.
32. Duncan R., Coatsworth J.K., Burtles S. Preclinical toxicology of a novel polymeric antitumour agent: HPMA copolymer-doxorubicin (PK1). Hum. Exp. Toxicol. 1998, 17:93-104.
33. Bonora G.M. Polymer-conjugated bioactive oligonucleotides. J. Bioact. Compat. Polym. 2002, 17:375-389.
34. Cammas-Marion S., Okano T., Kataoka K. Functional and site-specific macromolecular micelles as high potential drug carriers. Colloids Surf. B: Biointerfaces 1999, 16:207-215.
35. Sinha V.R., Aggarwal A., Trehan A. Biodegradable PEGylated microspheres and nanospheres. Am. J. Drug Deliv. 2004, 2:157-171.
36. Duewell S., Wuthrich R., von Schulthess G.K., Jenny H.B., Muller R.N., Moerker T., Fuchs W.A. Nonionic polyethylene glycol-ferrioxamine as a renal magnetic resonance contrast agent. Invest. Radiol. 1991, 26:50-57.
37. Barth H.G. Characterization of water-soluble polymers using size-exclusion chromatography. Adv. Chem. Series 1986, 213:31-55.
38. Nordmeier E.H. Characterization of polymers in solution with light scattering. Crit. Rev. Opt. Sci. Technol. 1997, 69:43-73.
39. Kaufman S.L., Skogen J.W., Dorman F.D., Zarrin F. Macromolecule determination based on electrophoretic mobility in air: globular proteins. Anal. Chem. 1996, 68:1895-1904.
40. Saucy D.A., Ude S., Lenggoro I.W., Fernandez de la Mora J. Mass analysis of water-soluble polymers by mobility measurement of charge-reduced ions generated by electrosprays. Anal. Chem. 2004, 76:1045-1053.
41. Bacher G., Szymanski W.W., Kaufman S.L., Zoellner P., Blaas D., Allmaier G. Charge-reduced nanoelectrospray ionization combined with differential mobility analysis of peptides, proteins, glycoproteins, noncovalent protein complexes and viruses. J. Mass Spectrom. 2001, 36:1038-1052.
42. Bahr U., Deppe A., Karas M., Hillenkamp F., Giessmann U. Mass spectrometry of synthetic polymers by UV-matrix-assisted laser desorption/ionization. Anal. Chem. 1992, 64:2866-2869.
43. Montaudo G., Samperi F., Montaudo M.S. Characterization of synthetic polymers by MALDI-MS. Progr. Polym. Sci. 2006, 31:277-357.
44. van Rooij G.J., Duursma M.C., Heeren R.M.A., Boon J.J., deKoster C.G. High resolution end group determination of low molecular weight polymers by matrix-assisted laser desorption ionization on an external ion source Fourier transform ion cyclotron resonance mass spectrometer. J. Am. Soc. Mass Spectrom. 1996, 7:449-457.
45. Karas M., Ehring H., Nordhoff E., Stahl B., Strupat K., Hillenkamp F., Grehl M., Krebs B. Matrix-assisted laser desorption/ionization mass spectrometry with additives to 2,5-dihydroxybenzoic acid. Org. Mass Spectrom. 1993, 28:1476-1481.
46. Harvey D.J. Matrix-assisted laser desorption/ionization mass spectrometry of carbohydrates. Mass Spectrom. Rev. 1999, 18:349-450.
47. Shimada K., Matsuyama S., Saito T., Kinugasa S., Nagahata R., Kawabata S. Conformational effects on cationization of poly(ethylene glycol) by alkali metal ions in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Int. J. Mass Spectrom. 2005, 247:85-92.